Teva Pharma sees 2013 revenue of about $20 bln
NEW YORK (MarketWatch) — Teva Pharmaceutical Industries Ltd. said Friday it expects adjusted 2013 profit of .85 a share to .15 a share, with revenue for the year of .5 billion to .5 billion. Wall Street analysts expect the generic drug maker to earn .62 a share on revenue of .76 billion, according to a survey by FactSet.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
